Hsa-let-7a functions as a tumor suppressor in renal cell carcinoma cell lines by targeting c-myc

Biochemical and Biophysical Research Communications

Volumn 417, Issue 1, 2012, Pages 371-375

  Liu, Yongchao ^a   Yin, Bingde ^a   Zhang, Changcun ^a   Zhou, Libin ^a   Fan, Jie ^a  

^a SHANGHAI FIRST PEOPLE S HOSPITAL   (China)

Author keywords

C myc; Cell cycle; Hsa let 7a; MicroRNAs; Proliferation; Renal cell carcinoma

Indexed keywords

CYCLIN D1; CYCLINE; LET 7A PROTEIN; MESSENGER RNA; MICRORNA; MICRORNA 17 92; MYC PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

CARCINOMA, RENAL CELL; CELL CYCLE; CELL LINE, TUMOR; CYCLIN D1; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; KIDNEY NEOPLASMS; MICRORNAS; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTO-ONCOGENE PROTEINS C-MYC;

EID: 84855779125     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.11.119     Document Type: Article

References (38)

1. Eilers M., Eisenman R.N. Myc's broad reach. Genes and Development 2008, 22:2755-2766.
2. Nesbit C.E., Tersak J.M., Prochownik E.V. MYC oncogenes and human neoplastic disease. Oncogene 1999, 18:3004-3016.
3. Pelengaris S., Khan M., Evan G. C-MYC: more than just a matter of life and death. Nature Reviews Cancer 2002, 2:764-776.
4. Vita M., Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Seminars in Cancer Biology 2006, 16:318-330.
5. Laurenti E., Wilson A., Trumpp A. Myc's other life: stem cells and beyond. Current Opinion in Cell Biology 2009, 21:844-854.
6. Wang H., Mannava S., Grachtchouk V., Zhuang D., Soengas M.S., Gudkov A.V., Prochownik E.V., Nikiforov M.A. C-Myc depletion inhibits proliferation of human tumor cells at various stages of the cell cycle. Oncogene 2008, 27:1905-1915.
7. Zornig M., Evan G.I. Cell cycle: on target with Myc. Current Biology 1996, 6:1553-1556.
8. Dews M., Homayouni A., Yu D., Murphy D., Sevignani C., Wentzel E., Furth E.E., Lee W.M., Enders G.H., Mendell J.T., Thomas-Tikhonenko A. Augmentation of tumor angiogenesis by a Myc-activated microRNA cluster. Nature Genetics 2006, 38:1060-1065.
9. Dang C.V. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Research 2010, 70:859-862.
10. Tang S.W., Chang W.H., Su Y.C., Chen Y.C., Lai Y.H., Wu P.T., Hsu C.I., Lin W.C., Lai M.K., Lin J.Y. MYC pathway is activated in clear cell renal cell carcinoma and essential for proliferation of clear cell renal cell carcinoma cells. Cancer Letters 2009, 273:35-43.
11. Lanigan D., McLean P.A., Murphy D.M., Donovan M.G., Curran B., Leader M. C-myc expression in renal carcinoma: correlation with clinical parameters. British Journal of Urology 1993, 72:143-147.
12. Liu Y., Zhang C., Fan J., Xiao L., Yin B., Zhou L., Xia S. Comprehensive analysis of clinical significance of stem-cell related factors in renal cell cancer. World Journal of Surgical Oncology 2011, 9:121.
13. Yamaguchi S., Yoshihiro S., Matsuyama H., Nagao K., Fukunaga K., Matsumoto H., Matsuda K., Oba K., Naito K. The allelic loss of chromosome 3p25 with c-myc gain is related to the development of clear-cell renal cell carcinoma. Clinical Genetics 2003, 63:184-191.
14. Peter M.E. Let-7 and miR-200 microRNAs: guardians against pluripotency and cancer progression. Cell Cycle 2009, 8:843-852.
15. Kim H.H., Kuwano Y., Srikantan S., Lee E.K., Martindale J.L., Gorospe M. HuR recruits let-7/RISC to repress c-Myc expression. Genes and Development 2009, 23:1743-1748.
16. Akao Y., Nakagawa Y., Naoe T. Let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biological and Pharmaceutical Bulletin 2006, 29:903-906.
17. Park S.M., Shell S., Radjabi A.R., Schickel R., Feig C., Boyerinas B., Dinulescu D.M., Lengyel E., Peter M.E. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 2007, 6:2585-2590.
18. Wong T.S., Man O.Y., Tsang C.M., Tsao S.W., Tsang R.K., Chan J.Y., Ho W.K., Wei W.I., To V.S. MicroRNA let-7 suppresses nasopharyngeal carcinoma cells proliferation through downregulating c-Myc expression. Journal of Cancer Research and Clinical Oncology 2010, 137:415-422.
19. He X.Y., Chen J.X., Zhang Z., Li C.L., Peng Q.L., Peng H.M. The let-7a microRNA protects from growth of lung carcinoma by suppression of k-Ras and c-Myc in nude mice. Journal of Cancer Research and Clinical Oncology 2009, 136:1023-1028.
20. Long X.B., Sun G.B., Hu S., Liang G.T., Wang N., Zhang X.H., Cao P.P., Zhen H.T., Cui Y.H., Liu Z. Let-7a microRNA functions as a potential tumor suppressor in human laryngeal cancer. Oncology Reports 2009, 22:1189-1195.
21. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
23. Olena A.F., Patton J.G. Genomic Organization of microRNAs. Journal of Cellular Physiology 2010, 222:540-545.
24. Eisenman R.N. Deconstructing myc. Genes and Development 2001, 15:2023-2030.
25. Soucek L., Evan G.I. The ups and downs of Myc biology. Current Opinion in Genetics and Development 2010, 20:91-95.
26. Amati B., Alevizopoulos K., Vlach J. Myc and the cell cycle. Frontiers in Bioscience 1998, 3:d250-268.
27. Mayanagi K., Kiyonari S., Nishida H., Saito M., Kohda D., Ishino Y., Shirai T., Morikawa K. Architecture of the DNA polymerase B-proliferating cell nuclear antigen (PCNA)-DNA ternary complex. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:1845-1849.
28. Moldovan G.L., Pfander B., Jentsch S. PCNA, the maestro of the replication fork. Cell 2007, 129:665-679.
29. Li F.Y., Cheng N.S., Cheng J.Q., Mao H., Jiang L.S., Li N., He S. Treatment of chronic proliferative cholangitis with c-myc shRNA. World Journal of Gastroenterology 2009, 15:95-101.
30. Huerta M., Munoz R., Tapia R., Soto-Reyes E., Ramirez L., Recillas-Targa F., Gonzalez-Mariscal L., Lopez-Bayghen E. Cyclin D1 is transcriptionally down-regulated by ZO-2 via an E box and the transcription factor c-Myc. Molecular Biology of the Cell 2007, 18:4826-4836.
31. Rohrs S., Kutzner N., Vlad A., Grunwald T., Ziegler S., Muller O. Chronological expression of Wnt target genes Ccnd1, Myc, Cdkn1a, Tfrc, Plf1 and Ramp3. Cell Biology International 2009, 33:501-508.
32. Dai Q.S., Liu W., Wang X.B., Lu N., Gong D.D., Kong L.Y., Guo Q.L. NCPMF-60 induces G2/M cell cycle arrest and apoptosis in human hepatocellular carcinoma HepG2 cells. Anti-Cancer Drugs 2011, 22:46-57.
33. Ota A., Tagawa H., Karnan S., Tsuzuki S., Karpas A., Kira S., Yoshida Y., Seto M. Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. Cancer Research 2004, 64:3087-3095.
34. O'Donnell K.A., Wentzel E.A., Zeller K.I., Dang C.V., Mendell J.T. C-Myc-regulated microRNAs modulate E2F1 expression. Nature 2005, 435:839-843.
35. Mendell J.T. MiRiad roles for the miR-17-92 cluster in development and disease. Cell 2008, 133:217-222.
36. van Haaften G., Agami R. Tumorigenicity of the miR-17-92 cluster distilled. Genes and Development 2010, 24:1-4.
37. Huang Y., Dai Y., Yang J., Chen T., Yin Y., Tang M., Hu C., Zhang L. Microarray analysis of microRNA expression in renal clear cell carcinoma. European Journal of Surgical Oncology 2009, 35:1119-1123.
38. Chow T.F., Mankaruos M., Scorilas A., Youssef Y., Girgis A., Mossad S., Metias S., Rofael Y., Honey R.J., Stewart R., Pace K.T., Yousef G.M. The miR-17-92 cluster is over expressed in and has an oncogenic effect on renal cell carcinoma. Journal of Urology 2010, 183:743-751.